Figure 6.

Efficiency of patient-derived ToC generation

(A) Workflow from surgery to ToCs and live-imaging microscopy. Right after the surgery, the tumor sample is transferred from the hospital to the research facility. Autologous cancer cells and tumor-infiltrating CD8⁺ CTLs are isolated by MACS and immediately used to generate ToC platforms.

(B) Efficiency of patient-derived cell isolation. For each patient, the tumor sample size, the number and viability of CD8⁺ CTLs and cancer living cells retrieved, the number of generated ToC, and the drug treatment are indicated.